Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
The Journal of Applied Psychology
|
April 1, 1992
Phrase-spaced formats improve comprehension in average readers
S Jandreau, T Bever
Current Treatment Options in Neurology
|
November 30, 2000
Multiple Sclerosis: Symptomatic Treatment
C T Bever
Annals of Neurology
|
January 1, 1994
The current status of studies of aminopyridines in patients with multiple sclerosis
C T Bever
Neurochemical Research
|
July 1, 1990
Astrocytosis and cathepsin D activity in experimental measles encephalomyelitis
C T Bever, P Swoveland
Immunopharmacology and Immunotoxicology
|
August 1, 1996
Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C
Q Li, C T Bever
Oncology Reports
|
April 4, 1998
Effect of protein kinase modulators on the regulation of cathepsin B activity in THP-1 human monocytic leukemia cells
Q Li, C T Bever
Journal of Neuroimmunology
|
April 1, 1997
Interferon-gamma induced increases in intracellular cathepsin B activity in THP-1 cells are dependent on RNA transcription
Q Li, C T Bever
Cell Biology International
|
November 26, 1998
Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists
Q Li, C T Bever
Journal of Neuroimmunology
|
December 11, 1991
Augmented IgG anti-acetylcholine receptor response following chronic penicillamine administration
C T Bever, R Asofsky
Brain Research. Molecular Brain Research
|
February 27, 2001
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells
Q Q Li, C T Bever
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
The Journal of Applied Psychology
|
April 1, 1992
Phrase-spaced formats improve comprehension in average readers
S Jandreau, T Bever
Current Treatment Options in Neurology
|
November 30, 2000
Multiple Sclerosis: Symptomatic Treatment
C T Bever
Annals of Neurology
|
January 1, 1994
The current status of studies of aminopyridines in patients with multiple sclerosis
C T Bever
Neurochemical Research
|
July 1, 1990
Astrocytosis and cathepsin D activity in experimental measles encephalomyelitis
C T Bever, P Swoveland
Immunopharmacology and Immunotoxicology
|
August 1, 1996
Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C
Q Li, C T Bever
Oncology Reports
|
April 4, 1998
Effect of protein kinase modulators on the regulation of cathepsin B activity in THP-1 human monocytic leukemia cells
Q Li, C T Bever
Journal of Neuroimmunology
|
April 1, 1997
Interferon-gamma induced increases in intracellular cathepsin B activity in THP-1 cells are dependent on RNA transcription
Q Li, C T Bever
Cell Biology International
|
November 26, 1998
Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists
Q Li, C T Bever
Journal of Neuroimmunology
|
December 11, 1991
Augmented IgG anti-acetylcholine receptor response following chronic penicillamine administration
C T Bever, R Asofsky
Brain Research. Molecular Brain Research
|
February 27, 2001
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells
Q Q Li, C T Bever
Page
of 10